Martindale Pharma® News Archives 2012

Martindale Pharma Enters the Wound Care Market

Published 12th November 2012

Drawtex®, First Product in Portfolio, Launched Today at Wounds UK Conference

Martindale Pharma® launches improved formulation of Physeptone Mixture 1mg/ml and Methadone Mixture DTF 1mg/ml

Published 6th November 2012

New alcohol and chloroform free formulation expected in pharmacies mid to late November.

Martindale Pharma® launches Caffeine 5mg/ml Oral Solution

Published 1st August 2012

Extends Critical Care Caffeine range with launch of oral product to improve ease of use.

Martindale Pharma® joins the 2012 Sunday Times Deloitte Buyout Track 100 Fastest Growing Companies

Published 8th February 2012

Martindale Pharma is pleased to announce that the Company has joined the Sunday Times Deloitte Buyout Track 100, as one of the top 100 fastest growing private equity backed companies in 2012

Martindale Pharma® launches Latanoprost eye drop solution

Published 18th January 2012

Martindale Pharma is pleased to announce the launch today of Latanoprost 0.005% w/v eye drop solution (2.5ml solution), a first in line treatment for Glaucoma